INZEN THERAPEUTICS, INC. – Trademark Portfolio

Entity Type: 03

INZEN THERAPEUTICS, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INZEN. The owner is based in CAMBRIDGE, MA.

55 CAMBRIDGE PARKWAY

SUITE 800E

CAMBRIDGE, MA 02142

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

INZEN THERAPEUTICS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does INZEN THERAPEUTICS, INC. have?

INZEN THERAPEUTICS, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned.

What trademark classes does INZEN THERAPEUTICS, INC. file in?

INZEN THERAPEUTICS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are INZEN THERAPEUTICS, INC.'s most well-known trademarks?

INZEN THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as INZEN. These are among 1 currently registered trademark in the portfolio.

What is INZEN THERAPEUTICS, INC.'s trademark registration success rate?

INZEN THERAPEUTICS, INC. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.